Relmada Therapeutics recently added to the claims in its lawsuit against the Laidlaw Company. According to Relmada Therapeutics, Laidlaw disclosed its confidential information. There are also alleges that Laidlaw gave misguiding information which they had to respond to. Relmada Therapeutics says it will need compensation on the claims. Laidlaw and two of its officials James Ahern and Matthew Eitner were given a restraining order. Relmada has kept their stakeholders informed on the proceedings of the lawsuit officially through letters.
The two companies were brought together by business. Laidlaw was the investment banker of Relmada Therapeutics. They began having problems when Laidlaw acted on Relmada’s intention to seek more investors without their knowledge. In my opinion, Laidlaw should have offered their advice on the best investors or involve Relmada in seeking investors. There were previous attempts to improve the relationship between these companies, but they were not successful.
Relmada has incurred losses following the actions of Laidlaw. This has also been reflected in the drop in their prices in the stock market. I believe that this is the reason why the company is claiming monetary compensation. Laidlaw has previously been accused of going against financial regulations and state laws.
Laidlaw was previously known as Sands Brothers International Ltd. The company provides financial services including investment banking and giving advice on the management of funds and wealth. Laidlaw is led by Mr. Matthew Eitner as the CEO and Mr. James Ahern as Managing Partner. Because of their positions, the two are greatly involved in the company’s activities.
The Laidlaw Company operates in the United States and the United Kingdom. It has its headquarters in New York. The company has also planned to expand in Europe. This is to allow for the provision of services to more people. There have also been some changes in the executive team to ease the expansion process.